Search

Search Constraints

You searched for: Author/Creator Smit, Egbert F

Search Results

3. CMET-22. CAPMATINIB (INC280) IN METΔEX14-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): EFFICACY DATA FROM THE PHASE 2 GEOMETRY MONO-1 STUDY. (11th November 2019)

4. Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial. Issue 1 (January 2023)

5. Combined sputum hypermethylation and eNose analysis for lung cancer diagnosis. Issue 8 (10th June 2014)

6. Dabrafenib in patients with BRAFV600E-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial. Issue 5 (May 2016)

7. Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial. Issue 10 (October 2017)

8. Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy. (March 2015)

9. Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy. (March 2015)

10. Detecting resistance in EGFR-mutated non-small-cell lung cancer after clonal selection through targeted therapy. (March 2015)